Bridge City Capital, LLC

Position in KRYS — Krystal Biotech, Inc.

CIK 1713521 LAKE OSWEGO, OR

Position in KRYS

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$3,111,464

+$119,702 QoQ

Shares Held

12,045

-0.7% QoQ

Ownership

0.041%

of shares outstanding

% of Portfolio

0.86%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2025

3 quarters on record

Voting authority Sole 55% Shared 0% None 45%

Healthcare · as of Mar 31, 2026

Bridge City Capital, LLC holds $13,944,831 across 5 Biotechnology names. KRYS ranks #2 (22.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	CPRX	Catalyst Pharmaceuticals, Inc.	155,689	$3,854,859
2	KRYS	Krystal Biotech, Inc. This page	12,045	$3,111,464
3	TGTX	Tg Therapeutics, Inc.	90,634	$3,010,861
4	CORT	Corcept Therapeutics Inc	54,874	$2,211,970
5	VCEL	Vericel Corp	54,575	$1,755,677

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$3,111,464	12,045	-0.7%	Shares	Sole	2026-05-13
2025-12-31	$2,991,762	12,135	-14.3%	Shares	Sole	2026-02-13
2025-09-30	$2,498,605	14,154	—	Shares	Sole	2025-11-12
No filing history on record for this holder in this stock.